BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 24561179)

  • 21. Effect of Processed Onions on the Plasma Concentration of Quercetin in Rats and Humans.
    Kashino Y; Murota K; Matsuda N; Tomotake M; Hamano T; Mukai R; Terao J
    J Food Sci; 2015 Nov; 80(11):H2597-602. PubMed ID: 26375490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidative flavonoid quercetin: implication of its intestinal absorption and metabolism.
    Murota K; Terao J
    Arch Biochem Biophys; 2003 Sep; 417(1):12-7. PubMed ID: 12921774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiologically based pharmacokinetic modeling of cyclotrimethylenetrinitramine in male rats.
    Krishnan K; Crouse LC; Bazar MA; Major MA; Reddy G
    J Appl Toxicol; 2009 Oct; 29(7):629-37. PubMed ID: 19629953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quercetin glucuronides but not glucosides are present in human plasma after consumption of quercetin-3-glucoside or quercetin-4'-glucoside.
    Sesink AL; O'Leary KA; Hollman PC
    J Nutr; 2001 Jul; 131(7):1938-41. PubMed ID: 11435510
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enzymatically modified isoquercitrin, alpha-oligoglucosyl quercetin 3-O-glucoside, is absorbed more easily than other quercetin glycosides or aglycone after oral administration in rats.
    Makino T; Shimizu R; Kanemaru M; Suzuki Y; Moriwaki M; Mizukami H
    Biol Pharm Bull; 2009 Dec; 32(12):2034-40. PubMed ID: 19952424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Flavonoid conjugates interact with organic anion transporters (OATs) and attenuate cytotoxicity of adefovir mediated by organic anion transporter 1 (OAT1/SLC22A6).
    Wong CC; Botting NP; Orfila C; Al-Maharik N; Williamson G
    Biochem Pharmacol; 2011 Apr; 81(7):942-9. PubMed ID: 21244849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. alpha-Oligoglucosylation of a sugar moiety enhances the bioavailability of quercetin glucosides in humans.
    Murota K; Matsuda N; Kashino Y; Fujikura Y; Nakamura T; Kato Y; Shimizu R; Okuyama S; Tanaka H; Koda T; Sekido K; Terao J
    Arch Biochem Biophys; 2010 Sep; 501(1):91-7. PubMed ID: 20638359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal absorption of hawthorn flavonoids--in vitro, in situ and in vivo correlations.
    Zuo Z; Zhang L; Zhou L; Chang Q; Chow M
    Life Sci; 2006 Nov; 79(26):2455-62. PubMed ID: 16989871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disposition and metabolism of [2-14C]quercetin-4'-glucoside in rats.
    Graf BA; Mullen W; Caldwell ST; Hartley RC; Duthie GG; Lean ME; Crozier A; Edwards CA
    Drug Metab Dispos; 2005 Jul; 33(7):1036-43. PubMed ID: 15833931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the bioavailability of quercetin and catechin in rats.
    Manach C; Texier O; Morand C; Crespy V; Régérat F; Demigné C; Rémésy C
    Free Radic Biol Med; 1999 Dec; 27(11-12):1259-66. PubMed ID: 10641719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
    Shin SC; Choi JS; Li X
    Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary and plasma levels of resveratrol and quercetin in humans, mice, and rats after ingestion of pure compounds and grape juice.
    Meng X; Maliakal P; Lu H; Lee MJ; Yang CS
    J Agric Food Chem; 2004 Feb; 52(4):935-42. PubMed ID: 14969553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of the flavonol quercetin in cows after intraruminal application of quercetin aglycone and rutin.
    Berger LM; Wein S; Blank R; Metges CC; Wolffram S
    J Dairy Sci; 2012 Sep; 95(9):5047-5055. PubMed ID: 22916908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability of rutin and quercetin in rats.
    Manach C; Morand C; Demigné C; Texier O; Régérat F; Rémésy C
    FEBS Lett; 1997 Jun; 409(1):12-6. PubMed ID: 9199494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Physiologically based pharmacokinetic modeling of deltamethrin: development of a rat and human diffusion-limited model.
    Godin SJ; DeVito MJ; Hughes MF; Ross DG; Scollon EJ; Starr JM; Setzer RW; Conolly RB; Tornero-Velez R
    Toxicol Sci; 2010 Jun; 115(2):330-43. PubMed ID: 20200215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Deconjugation and degradation of flavonol glycosides by pig cecal microbiota characterized by Fluorescence in situ hybridization (FISH).
    Hein EM; Rose K; van't Slot G; Friedrich AW; Humpf HU
    J Agric Food Chem; 2008 Mar; 56(6):2281-90. PubMed ID: 18303842
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal transport of quercetin glycosides in rats involves both deglycosylation and interaction with the hexose transport pathway.
    Gee JM; DuPont MS; Day AJ; Plumb GW; Williamson G; Johnson IT
    J Nutr; 2000 Nov; 130(11):2765-71. PubMed ID: 11053519
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Absorption and disposition of naringenin and quercetin after simultaneous administration via intestinal perfusion in mice.
    Orrego-Lagarón N; Martínez-Huélamo M; Quifer-Rada P; Lamuela-Raventos RM; Escribano-Ferrer E
    Food Funct; 2016 Sep; 7(9):3880-9. PubMed ID: 27515345
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prediction of dose-dependent in vivo acetylcholinesterase inhibition by profenofos in rats and humans using physiologically based kinetic (PBK) modeling-facilitated reverse dosimetry.
    Omwenga I; Zhao S; Kanja L; Mol H; Rietjens IMCM; Louisse J
    Arch Toxicol; 2021 Apr; 95(4):1287-1301. PubMed ID: 33651127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioconversion of quercetin and rutin and the cytotoxicity activities of the transformed products.
    Araújo KC; de M B Costa EM; Pazini F; Valadares MC; de Oliveira V
    Food Chem Toxicol; 2013 Jan; 51():93-6. PubMed ID: 23000251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.